Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephan Hois
Stephan Hois
Novartis
Phases of clinical research
Myeloid leukemia
Medicine
Oncology
Internal medicine
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib.
2018
Journal of Clinical Oncology
Michael J. Mauro
Fabian Lang
Dong-Wook Kim
Jorge E. Cortes
Timothy P. Hughes
Andreas Hochhaus
Hironobu Minami
Carla Boquimpani
Yosuke Minami
Daniel J. DeAngelo
Massimo Breccia
Moshe Talpaz
Yeow-Tee Goh
Oliver G. Ottmann
Manu Sondhi
Stephan Hois
Véronique Bédoucha
Shu-Fang Hsu Schmitz
Delphine Rea
Show All
Source
Cite
Save
Citations (1)
Clinical Development of Asciminib (ABL001): A Randomized Phase 3 Study of Asciminib vs Bosutinib in Patients with Chronic Myeloid Leukemia (CML)
2018
Clinical Lymphoma, Myeloma & Leukemia
Michael J. Mauro
Fabian Lang
Dong-Wook Kim
Jorge E. Cortes
Timothy P. Hughes
Andreas Hochhaus
Hironobu Minami
Carla Boquimpani
Yosuke Minami
Massimo Breccia
Yeow-Tee Goh
Oliver G. Ottmann
Manu Sondhi
Stephan Hois
Véronique Bédoucha
Kevin Perraud
Delphine Rea
Daniel J. DeAngelo
Show All
Source
Cite
Save
Citations (0)
Asciminib (ABL001) in Combination with Imatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Have Not Achieved a Deep Molecular Response with Long-Term Frontline Imatinib: A Randomized, Open-Label, Multicenter, Phase 2 Study
2018
Clinical Lymphoma, Myeloma & Leukemia
Jorge E. Cortes
Timothy P. Hughes
Jan Geissler
Stephan Hois
Sara Quenet
Florence Hourcade-Potelleret
Sabine Hertle
G. Saglio
Show All
Source
Cite
Save
Citations (0)
1